While the tobacco, pharma and alcohol industries have had more than a century to mature, integrate and capitalize in global markets – an entirely new beast emerged on October 17, 2018. You guessed it: the billion-dollar Canadian cannabis industry. Daniel Davidzon, Director of Strategy and Education at Cannvas MedTech, a leading digital cannabis education and analytics company, is pioneering the highly regulated space. With so many questions in the air, Daniel couples scientific and medical research to dissect the nuances dividing medical and recreational consumption on this episode of The Pivot.